SHANGHAI MICROPORT EP MEDTECH CO., LTD. Financials Shanghai MicroPort EP MedTech Co., Ltd.
Equities
688351
CNE100005PG9
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.38 CNY | +1.20% |
|
-1.44% | -1.05% |
| 02-26 | Shanghai MicroPort EP MedTech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 01-17 | MicroPort EP Medtech's Columbus Cardiac Mapping System Enters EU Market | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 12,457 | 12,071 | 11,944 | - | - |
| Enterprise Value (EV) 1 | 12,457 | 11,814 | 11,305 | 11,218 | 11,944 |
| P/E ratio | 3,781 x | 2,120 x | 272 x | 164 x | 88.5 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 47.9 x | 36.7 x | 25.4 x | 18 x | 13 x |
| EV / Revenue | 47.9 x | 35.9 x | 24.1 x | 16.9 x | 13 x |
| EV / EBITDA | 707 x | 376 x | 207 x | 114 x | 68.3 x |
| EV / FCF | -302 x | -148 x | -343 x | 601 x | 188 x |
| FCF Yield | -0.33% | -0.68% | -0.29% | 0.17% | 0.53% |
| Price to Book | 7.43 x | 7.16 x | 6.91 x | 6.64 x | 6.16 x |
| Nbr of stocks (in thousands) | 470,600 | 470,600 | 470,600 | - | - |
| Reference price 2 | 26.47 | 25.65 | 25.38 | 25.38 | 25.38 |
| Announcement Date | 23-02-17 | 24-02-27 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 260.3 | 329.2 | 470 | 662.1 | 919 |
| EBITDA 1 | - | 17.62 | 31.38 | 54.48 | 98.65 | 174.8 |
| EBIT 1 | - | 3.026 | 7.646 | 43.04 | 85.99 | 159.3 |
| Operating Margin | - | 1.16% | 2.32% | 9.16% | 12.99% | 17.33% |
| Earnings before Tax (EBT) 1 | - | 2.972 | 5.61 | 41.24 | 83.32 | 157.6 |
| Net income 1 | -11.97 | 2.972 | 5.689 | 40.33 | 73.49 | 135 |
| Net margin | - | 1.14% | 1.73% | 8.58% | 11.1% | 14.69% |
| EPS 2 | -0.0299 | 0.007000 | 0.0121 | 0.0933 | 0.1543 | 0.2867 |
| Free Cash Flow 1 | - | -41.31 | -79.9 | -33 | 18.67 | 63.5 |
| FCF margin | - | -15.87% | -24.27% | -7.02% | 2.82% | 6.91% |
| FCF Conversion (EBITDA) | - | - | - | - | 18.92% | 36.32% |
| FCF Conversion (Net income) | - | - | - | - | 25.4% | 47.04% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 22-08-10 | 23-02-17 | 24-02-27 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2024 Q1 |
|---|---|
| Net sales 1 | 89.15 |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income 1 | 4.169 |
| Net margin | 4.68% |
| EPS 2 | 0.008900 |
| Dividend per Share | - |
| Announcement Date | 24-04-24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | - | - | 256 | 639 | 726 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -41.3 | -79.9 | -33 | 18.7 | 63.5 |
| ROE (net income / shareholders' equity) | - | 0.31% | 0.34% | 2.23% | 4.14% | 7.06% |
| ROA (Net income/ Total Assets) | - | 0.24% | 0.31% | 1.7% | 3.18% | 4.5% |
| Assets 1 | - | 1,229 | 1,808 | 2,373 | 2,314 | 3,000 |
| Book Value Per Share 2 | - | 3.560 | 3.580 | 3.670 | 3.830 | 4.120 |
| Cash Flow per Share 2 | - | -0.0200 | -0.0800 | 0.0600 | 0.1100 | 0.2300 |
| Capex 1 | - | 31.9 | 41.9 | 77.4 | 81.1 | 104 |
| Capex / Sales | - | 12.26% | 12.74% | 16.47% | 12.24% | 11.31% |
| Announcement Date | 22-08-10 | 23-02-17 | 24-02-27 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
25.38
CNY
Average target price
28.11
CNY
Spread / Average Target
+10.74%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -1.05% | 1.65B | |
| -19.42% | 18.12B | |
| -41.90% | 2.87B | |
| +19.36% | 1.9B | |
| +33.96% | 1.34B | |
| -16.83% | 957M | |
| -21.96% | 896M | |
| +7.07% | 841M | |
| +10.85% | 523M | |
| -.--% | 486M |
- Stock Market
- Equities
- 688351 Stock
- Financials Shanghai MicroPort EP MedTech Co., Ltd.
